PPAR-γ agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 4, 2009, Pages

  Roberts, Tim J M ^b   Chapman, Abbie C ^a   Cipolla, Marilyn J ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute hypertension; Cerebral veins; Hydraulic conductivity

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ROSIGLITAZONE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN VEIN; CONTROLLED STUDY; DRINKING; ENZYME INHIBITION; FEMALE; FILTRATION; HYDRAULIC CONDUCTIVITY; HYDROSTATIC PRESSURE; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; BRAIN EDEMA; CAPILLARY PERMEABILITY; CEREBRAL VEINS; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; CYCLIC N-OXIDES; DISEASE MODELS, ANIMAL; FEMALE; HYDROSTATIC PRESSURE; HYPERTENSION; NG-NITROARGININE METHYL ESTER; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; SPIN LABELS; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 70349620982     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00630.2009     Document Type: Article

References (53)

1. Ahishali B, Kaya M, Kalayci R, Uzun H, Bilgic B, Arican N, Elmas I, Aydin S, Kucuk M. Effects of lipopolysaccharide on the blood-brain barrier permeability in prolonged nitric oxide blockade-induced hypertensive rats. Int J Neurosci 115: 151-168, 2005. (Pubitemid 40066070)
2. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 106: 1977-1982, 2009.
3. Auer L, Johansson B, MacKenzie ET. Cerebral venous pressure during actively induced hypertension and hypercapnia in cats. Stroke 11: 180-183, 1980. (Pubitemid 10133604)
4. Baldwin A, Wilson L. Endothelium increases medial hydraulic conductance of aorta, possibly by release of ERDF. Am J Physiol Heart Circ Physiol 264: H26-H32, 1993. (Pubitemid 23059121)
5. Baldwin AL, Wilson LM, Gradus-Pizlo I, Wilensky R, March K. Effect of atherosclerosis on transmural convection and arterial ultrastructure: implications for local intravascular drug delivery. Arterioscler Thromb Vasc Biol 17: 3365-3375, 1997.
6. Barron WM. Volume homeostasis during pregnancy in the rat. Am J Kidney Dis 9: 296-302, 1987.
7. Beyer AM, Baumbach GL, Halabi CM, Modrick ML, Lynch CM, Gerhold TD, Ghoneim SM, de Lange WJ, Keen HL, Tsai YS, Maeda N, Sigmund CD, Faraci FM. Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension 51: 867-871, 2008. (Pubitemid 351654697)
8. Butt AM, Jones HC, Abbott NJ. Electrical resistance across the bloodbrain barrier in anaesthetized rats: a developmental study. J Physiol 429: 47-62, 1990. (Pubitemid 20327537)
9. Cipolla MJ, Crete R, Vitullo L, Rix R. Transcellular transport as a mechanism of blood-brain barrier disruption during stroke. Front Biosci 9: 777-785, 2004. (Pubitemid 39043750)
10. Cipolla MJ, DeLance N, Vitullo L. Pregnancy prevents hypertensive remodeling of cerebral arteries: A potential role in the development of eclampsia. Hypertension 47: 619-626, 2006. (Pubitemid 43843886)
11. Duan SZ, Usher MG, Mortensen RM. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res 102: 283-294, 2008.
12. Erley CM, Rebmann S, Strobel U, Schmidt T, Wehrmann M, Osswald H, Risler T. Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis. Exp Nephrol 3: 293-299, 1995.
13. Fraser PA, Dallas DA, Davies S. Measurement of filtration coefficient in single cerebral microvessels of the frog. J Physiol 423: 343-361, 1990.
14. Halpern W, Osol G, Coy GS. Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng 12: 463-479, 1984. (Pubitemid 15149742)
15. Huang W, Eum SY, András IE, Hennig B, Toborek M. PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J 23: 1596-1606, 2009.
16. Ishii S, Koike J, Hatashita. Brain edema in hypertensive intracranial hemorrhage. In: Hypertensive Intracranial Hemorrhage, edited by Mizukami M. New York: Raven, 1983.
17. Kalayci R, Kaya M, Elmas I, Arican N, Ahishali B, Uzun H, Bilgic B, Kucuk M, Kudat H. Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats. Brain Res 1042: 184-193, 2005. (Pubitemid 40591728)
18. Kimelberg HK. Water homeostasis in the brain: basic concepts. Neuroscience 129: 851-860, 2004.
19. Kimura M, Dietrich HH, Huxley VH, Reichner DR, Dacey RG Jr. Measurement of hydraulic conductivity in isolated arterioles of rat brain cortex. Am J Physiol Heart Circ Physiol 264: H1788-H1797, 1993. (Pubitemid 23205948)
20. Kniesel U, Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 20: 57-76, 2000.
21. Kucuk M, Kaya M, Kalayci R, Cimen V, Kudat H, Arican N, Elmas I, Korkut F. Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats. Life Sci 71: 937-946, 2002. (Pubitemid 34655822)
22. Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, Wolburg H. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol (Berl) 100: 323-331, 2000. (Pubitemid 30456160)
23. Mayhan WG. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 866: 101-108, 2000. (Pubitemid 30313012)
24. Mayhan WG. Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. Brain Res 686: 99-103, 1995.
25. Mayhan WG, Heistad DD. Permeability of blood-brain barrier to various sized molecules. Am J Physiol Heart Circ Physiol 248: H712-H718, 1985. (Pubitemid 15027173)
26. Mayhan WG, Heistad DD. Role of veins and cerebral venous pressure in disruption of the blood-brain barrier. Circ Res 59: 216-220, 1986.
27. Michel CC, Mason JC, Curry FE, Tooke JE, Hunter PJ. A development of the Landis technique for measuring the filtration coefficient of individual capillaries in the frog mesentery. Q J Exp Physiol Cogn Med Sci 59: 283-309, 1974.
28. Morton JJ, Beattie EC, Speirs A, Gulliver F. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypertens 11: 1083-1088, 1993. (Pubitemid 23307881)
29. Mueller SM, Heistad DD. Effect of chronic hypertension on the bloodbrain barrier. Hypertension 2: 809-812, 1980.
30. Nag S, Robertson DM, Dinsdale HB. Cerebral cortical changes in acute experimental hypertension: an ultrastructural study. Lab Invest 36: 150-161, 1977. (Pubitemid 8056209)
31. Nakamura T, Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ogawa H, Kim-Mitsuyama S. Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Stroke 38: 3016-3022, 2007. (Pubitemid 350041562)
32. Nicolakakis N, Aboulkassim T, Ongali B, Lecrux C, Fernandes P, Rosa-Neto P, Tong XK, Hamel E. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J Neurosci 10: 9287-9296, 2008.
33. Nordstrom CH. Physiological and biochemical principles underlying volume-targeted therapy - the "Lund concept". Neurocrit Care 2: 83-95, 2005.
34. Oztaş B, Erkin E, Dural E, Isbir T. Influence of antioxidants on blood-brain barrier permeability during adrenaline-induced hypertension. Int J Neurosci 105: 27-35, 2000. (Pubitemid 30813526)
35. Park JB, Touyz RM, Chen X, Schiffrin EL. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15: 78-84, 2002. (Pubitemid 34102277)
36. Povlishock JT, Kontos HA, Rosenblum WI, Becker DP, Jenkins LW, De Witt DS. A scanning electron-microscopic analysis of the intraparenchymal brain vasculature following experimental hypertension. Acta Neuropathol (Berl) 51: 203-213, 1980.
37. Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res 43: 348-364, 2009.
38. Qiu CB, Engels K, Samsell L, Baylis C. Renal effects of acute amino acid infusion in hypertension induced by chronic nitric oxide blockade. Hypertension 25: 61-66, 1995.
39. Ramirez SH, Heilman D, Morsey B, Potula R, Haorah J, Persidsky Y. Activation of peroxisome proliferator-activated receptor gamma (PPARγ ) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes. J Immunol 180: 1854-1865, 2008.
40. Rapoport SI. Brain edema and the blood-brain barrier. In: Primer on Cerebrovascular Disease, edited by Welch KMA, Caplan LR, Reis DJ, Siesjo BK, Weir B. San Diego, CA: Academic, 1997, p. 25-28.
41. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci 22: 11-28, 1999.
42. Rumbaut RE, Wang J, Huxley VH. Differential effects of L-NAME on rat venular hydraulic conductivity. Am J Physiol Heart Circ Physiol 279: H2017-H2023, 2000.
43. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD. PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 43(3): 661-666, 2004. (Pubitemid 38282444)
44. Sainz J, Wangensteen R, Rodríguez Gómez I, Moreno JM, Chamorro V, Osuna A, Bueno P, Vargas F. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Am J Hypertens 18: 871-877, 2005. (Pubitemid 40745276)
45. Shou Y, Jan KM, Rumschitzki DS. Transport in rat vessel walls. I. Hydraulic conductivities of the aorta, pulmonary artery, and inferior vena cava with intact and denuded endothelia. Am J Physiol Heart Circ Physiol 291: H2758-H2771, 2006. (Pubitemid 44904076)
46. Simonsen U, Christensen FH, Buus NH. The effect of tempol on endothelium-dependent vasodilatation and blood pressure. Pharmacol Ther 122: 109-124, 2009.
47. Tamaki K, Sadoshima S, Baumbach GL, Iadecola C, Reis DJ, Heistad DD. Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy. Hypertension 6: I75-I81, 1984. (Pubitemid 14113585)
48. Tureyen K, Kapadia R, Bowen KK, Satriotomo I, Liang J, Feinstein DL, Vemuganti R. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem 101: 41-56, 2007. (Pubitemid 46426485)
49. van Vliet EA, da Costa Araú jo S, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130: 521-534, 2007.
50. Wei EP, Kontos HA, Christman CW, DeWitt DS, Povlishock JT. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ Res 57: 781-787, 1985.
51. Yi JH, Park SW, Brooks N, Lang BT, Vemuganti R. PPAR gamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res 1244: 164-172, 2008.
52. Zatz R, Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998. (Pubitemid 29001420)
53. Zhao Q, Egashira K, Inoue S, Usui M, Kitamoto S, Ni W, Ishibashi M, Hiasa Ki K, Ichiki T, Shibuya M, Takeshita A. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 105: 1110-1115, 2002. (Pubitemid 34212623)